Integrated Cannabis Company Inc reports the completion and positive results of a controlled trial of its proprietary sleep product.
The 60-patient trial was completed with a pain clinic in Southern California and the results were highly favorable; resulting in improvement in patients’ sleep patterns combined with the unexpected, but highly desirable, decrease in the level of pain. The study results have been published in the International Journal of Pharmacy and Life Sciences (Vol 9:5722-5729).
“The unique formulation of ingredients in the X-SPRAYS sleep supplement contributed to a significant improvement in sleep quality together with a reduction in daytime sleepiness, pain, and depression, when compared to the control group,” says Clive Spray, PhD, BSc, chief science officer of Integrated Cannabis, in a release. “The study was conducted in a controlled and regulated clinical environment, which prohibits the test of cannabis products. Therefore the study was on our non-cannabinoid product. However, our experience with the infusion of CBD into the tested formulation has rendered profound increased benefits. Furthermore, we are actively seeking clinical study relationships in legal jurisdictions outside of North America for our cannabinoid-based products and expect to replicate the aforementioned study in the near term. The spray has the added benefit of being easy to use, is fast acting, promotes a superb night’s rest and does not leave you feeling groggy in the morning,”